TWD 14.35
(-22.85%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.71 Billion TWD | 5.08% |
2022 | 1.62 Billion TWD | 2.19% |
2021 | 1.59 Billion TWD | 6.34% |
2020 | 1.49 Billion TWD | -7.32% |
2019 | 1.61 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.66 Billion TWD | -2.75% |
2024 Q2 | 1.66 Billion TWD | 0.0% |
2023 Q4 | 1.71 Billion TWD | 0.0% |
2023 FY | 1.71 Billion TWD | 5.08% |
2023 Q3 | 1.71 Billion TWD | 4.4% |
2023 Q2 | 1.64 Billion TWD | 0.0% |
2023 Q1 | 1.64 Billion TWD | 0.65% |
2022 FY | 1.62 Billion TWD | 2.19% |
2022 Q4 | 1.62 Billion TWD | 0.0% |
2022 Q3 | 1.62 Billion TWD | 0.0% |
2021 FY | 1.59 Billion TWD | 6.34% |
2020 FY | 1.49 Billion TWD | -7.32% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -1237.293% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 40.971% |
Level Biotechnology Inc. | 822.67 Million TWD | -108.146% |
Sagittarius Life Science Corp | 664.72 Million TWD | -157.605% |
NeoCore Technology Co., Ltd. | 548.74 Million TWD | -212.049% |
TaiMed Biologics Inc. | 3.89 Billion TWD | 56.025% |
GlycoNex Incorporation | 1.55 Billion TWD | -10.275% |
VBI | 452.1 Million TWD | -278.756% |
GeneReach Biotechnology Corp. | 1.17 Billion TWD | -45.592% |
Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -128.751% |
SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -352.573% |
Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -51.023% |
Visgeneer Inc. | 397.17 Million TWD | -331.135% |
Mycenax Biotech Inc. | 3.77 Billion TWD | 54.584% |
Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 20.688% |
G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -93.905% |
Neith Corporation | 192.15 Million TWD | -791.146% |
Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 71.895% |
TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -2227.909% |
Enimmune corporation | 604.82 Million TWD | -183.116% |
TaiRx, Inc. | 833.74 Million TWD | -105.382% |
CHO Pharma, Inc. | 3.08 Billion TWD | 44.512% |
EirGenix Inc. | 11.16 Billion TWD | 84.66% |
BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -198.769% |
Lin BioScience, Inc. | 3.59 Billion TWD | 52.391% |
BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -63.008% |
Feng Chi Biotech Corp. | 301.03 Million TWD | -468.831% |
Bio Preventive Medicine Corp. | 264.65 Million TWD | -547.012% |
Lukas Biomedical Inc. | 441.19 Million TWD | -288.123% |
RBC Bioscience Corporation | 753.79 Million TWD | -127.167% |
BiOptic Inc. | 613.77 Million TWD | -178.99% |
BRIM Biotechnology, Inc. | 1.77 Billion TWD | 3.728% |
Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -47.654% |
Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -165.545% |
Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 44.874% |
Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1057.518% |
NaviFUS Corp. | 490.53 Million TWD | -249.081% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -39.703% |
Sinew Pharma Inc. | 1.36 Billion TWD | -25.597% |
Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -223.609% |
Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -47.441% |
Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -3.386% |
AP Biosciences Inc | 890.75 Million TWD | -92.237% |
Medigen Biotechnology Corp. | 8.52 Billion TWD | 79.919% |
3D Global Biotech Inc. | 324.14 Million TWD | -428.266% |
Pharmosa Biopharm Inc. | 1.33 Billion TWD | -28.397% |
Intech Biopharm Corporation | 2.71 Billion TWD | 36.838% |
Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 88.854% |
Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -317.387% |
TWi Biotechnology, Inc. | 396.85 Million TWD | -331.488% |
Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 17.513% |
TCI GENE Inc. | 1.16 Billion TWD | -46.865% |
MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -481.288% |
Senhwa Biosciences, Inc. | 1.36 Billion TWD | -25.601% |
Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -81.826% |
NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -145.166% |
PharmaEngine, Inc. | 3.95 Billion TWD | 56.692% |
Savior Lifetec Corporation | 3.82 Billion TWD | 55.205% |
TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -39.235% |
OBI Pharma, Inc. | 5.6 Billion TWD | 69.443% |
Meribank Biotech Co., Ltd | 1.06 Billion TWD | -61.238% |
Acepodia, Inc. | 6.81 Billion TWD | 74.887% |
Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 55.25% |